Major Depressive Disorder

Latest News

depression
FDA Grants Fast Track Designation for NRX-100 for Suicidal Ideation in Patients With Depression, Including Bipolar Depression

August 11th 2025

NRx Pharmaceuticals secures FDA Fast Track designation for NRX-100, a preservation-free formulation of intravenous ketamine for suicidal ideation in depression.

psychopharmacology
Recent Updates in Psychopharmacology: Insights in Schizophrenia, ADHD, and Treatment-Resistant Depression

August 8th 2025

neurodevelopmental disorder suicide risk
Suicide Risk Screening for Children With Neurodevelopmental Disabilities: New Insights

August 7th 2025

depression
Major Depressive Disorder Research Roundup: July 25, 2025

July 25th 2025

depression prescription
Advantage of Augmenting Antidepressant Over Switching Qualified in New Analysis

July 25th 2025

Latest CME Events & Activities
<1
...
5152535455
© 2025 MJH Life Sciences

All rights reserved.